SK285099B6 - Spôsob výroby retardovaného viaczložkového prípravku s riadeným a od pohybu nezávislým uvoľňovaním, jeho použitie a prípravok - Google Patents

Spôsob výroby retardovaného viaczložkového prípravku s riadeným a od pohybu nezávislým uvoľňovaním, jeho použitie a prípravok Download PDF

Info

Publication number
SK285099B6
SK285099B6 SK372-2001A SK3722001A SK285099B6 SK 285099 B6 SK285099 B6 SK 285099B6 SK 3722001 A SK3722001 A SK 3722001A SK 285099 B6 SK285099 B6 SK 285099B6
Authority
SK
Slovakia
Prior art keywords
release
polymer
active ingredient
hydroxypropylcellulose
particles
Prior art date
Application number
SK372-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK3722001A3 (en
Inventor
Venkata-Rangarao Kanikanti
Ronald Rupp
Erich Brendel
Claus Weisemann
Ernst Chantraine
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of SK3722001A3 publication Critical patent/SK3722001A3/sk
Publication of SK285099B6 publication Critical patent/SK285099B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Nonmetallic Welding Materials (AREA)
SK372-2001A 1998-09-18 1999-09-17 Spôsob výroby retardovaného viaczložkového prípravku s riadeným a od pohybu nezávislým uvoľňovaním, jeho použitie a prípravok SK285099B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19842753A DE19842753A1 (de) 1998-09-18 1998-09-18 Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung
PCT/EP1999/006882 WO2000016748A1 (de) 1998-09-18 1999-09-17 Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
SK3722001A3 SK3722001A3 (en) 2001-10-08
SK285099B6 true SK285099B6 (sk) 2006-06-01

Family

ID=7881376

Family Applications (1)

Application Number Title Priority Date Filing Date
SK372-2001A SK285099B6 (sk) 1998-09-18 1999-09-17 Spôsob výroby retardovaného viaczložkového prípravku s riadeným a od pohybu nezávislým uvoľňovaním, jeho použitie a prípravok

Country Status (29)

Country Link
US (1) US6805881B1 (ko)
EP (1) EP1113787B1 (ko)
JP (1) JP2002526437A (ko)
KR (1) KR100660072B1 (ko)
CN (1) CN1178650C (ko)
AT (1) ATE260645T1 (ko)
AU (2) AU5861499A (ko)
BG (1) BG105325A (ko)
BR (1) BR9913839A (ko)
CA (1) CA2344372C (ko)
DE (2) DE19842753A1 (ko)
DK (1) DK1113787T3 (ko)
EE (1) EE04700B1 (ko)
ES (1) ES2215404T3 (ko)
HK (1) HK1040932B (ko)
HR (1) HRP20010198A2 (ko)
HU (1) HUP0103669A3 (ko)
ID (1) ID28735A (ko)
IL (2) IL141532A0 (ko)
NO (1) NO20011211L (ko)
NZ (1) NZ510563A (ko)
PL (1) PL195543B1 (ko)
PT (1) PT1113787E (ko)
RU (1) RU2235540C2 (ko)
SK (1) SK285099B6 (ko)
TR (1) TR200100756T2 (ko)
UA (1) UA73097C2 (ko)
WO (2) WO2000016747A1 (ko)
ZA (1) ZA200101485B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005012561B4 (de) 2005-03-18 2008-06-19 Christian Beer Verfahren zum Betrieb eines Werkstück-Transfersystems
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
SG166126A1 (en) 2005-10-04 2010-11-29 Bayer Schering Pharma Ag Novel polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo- 3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CN100448432C (zh) * 2006-10-26 2009-01-07 徐竹青 高溶出度尼莫地平分散片的制备方法
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
US7952167B2 (en) * 2007-04-27 2011-05-31 Taiwan Semiconductor Manufacturing Company, Ltd. Scribe line layout design
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
TWI468191B (zh) * 2009-01-28 2015-01-11 Novartis Ag 有機化合物之調配物
US20100247646A1 (en) * 2009-03-26 2010-09-30 Ranbaxy Laboratories Limited Extended release tablets of nisoldipine
US20120070465A1 (en) 2010-03-29 2012-03-22 Astellas Pharma Inc. Pharmaceutical composition for modified release
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5482525A (en) 1977-12-13 1979-06-30 Aisan Ind Co Ltd Exhaust gas recirculation system
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4449983A (en) 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
DE3612211A1 (de) 1986-04-11 1987-10-15 Basf Ag Kontinuierliches verfahren zum tablettieren
DE3720757A1 (de) 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
DE3830353A1 (de) 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
JPH03145418A (ja) 1989-10-27 1991-06-20 Sumitomo Pharmaceut Co Ltd 塩基性薬物塩酸塩の徐放性製剤
KR0182801B1 (ko) 1991-04-16 1999-05-01 아만 히데아키 고체 분산체의 제조방법
DE4138513A1 (de) 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
FR2725624B1 (fr) 1994-10-14 1997-01-17 Jouveinal Inst Rech Procede de preparation de formes pharmaceutiques a liberation controlee
DE19504831A1 (de) 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose

Also Published As

Publication number Publication date
NZ510563A (en) 2002-10-25
EP1113787B1 (de) 2004-03-03
DE19842753A1 (de) 2000-03-23
KR100660072B1 (ko) 2006-12-22
AU750617B2 (en) 2002-07-25
DK1113787T3 (da) 2004-05-17
ZA200101485B (en) 2002-02-22
WO2000016748A1 (de) 2000-03-30
EP1113787A1 (de) 2001-07-11
EE200100161A (et) 2002-08-15
ID28735A (id) 2001-06-28
HRP20010198A2 (en) 2002-04-30
ATE260645T1 (de) 2004-03-15
BR9913839A (pt) 2001-06-12
TR200100756T2 (tr) 2001-07-23
UA73097C2 (en) 2005-06-15
NO20011211D0 (no) 2001-03-09
DE59908764D1 (de) 2004-04-08
AU5861499A (en) 2000-04-10
ES2215404T3 (es) 2004-10-01
IL141532A0 (en) 2002-03-10
NO20011211L (no) 2001-03-09
AU6191899A (en) 2000-04-10
CN1317959A (zh) 2001-10-17
HUP0103669A2 (hu) 2002-01-28
HK1040932A1 (en) 2002-06-28
CA2344372C (en) 2009-12-22
WO2000016747A1 (de) 2000-03-30
SK3722001A3 (en) 2001-10-08
PL346535A1 (en) 2002-02-11
EE04700B1 (et) 2006-10-16
KR20010073172A (ko) 2001-07-31
PT1113787E (pt) 2004-07-30
CA2344372A1 (en) 2000-03-30
PL195543B1 (pl) 2007-09-28
RU2235540C2 (ru) 2004-09-10
US6805881B1 (en) 2004-10-19
JP2002526437A (ja) 2002-08-20
HK1040932B (zh) 2005-08-05
CN1178650C (zh) 2004-12-08
BG105325A (bg) 2001-11-30
HUP0103669A3 (en) 2006-07-28
IL141532A (en) 2007-03-08

Similar Documents

Publication Publication Date Title
SK285099B6 (sk) Spôsob výroby retardovaného viaczložkového prípravku s riadeným a od pohybu nezávislým uvoľňovaním, jeho použitie a prípravok
JP6240279B2 (ja) 制御放出ヒドロコドン処方
RU2136283C1 (ru) Препарат с контролируемым высвобождением лекарства и способ его получения, способ лечения
EP1940361B1 (en) Pharmaceutical dosage forms having immediate release and/or controlled release properties
KR102213616B1 (ko) 토파시티닙 경구용 지속 방출 투여 형태
JP3350559B2 (ja) 活性成分を含有する予め成形された微小粒子より製造される機械的に安定でかつ容易に分解し得る錠剤
SK656388A3 (en) Pharmaceutical preparation consisting of granules with tetracycline compound
JP2003508430A (ja) トラマドールサッカリナートを含有する徐放性投薬形
RU2340331C2 (ru) Форма пролонгированного высвобождения венлафаксина гидрохлорида
WO2005084636A2 (en) A process for the preparation of controlled-release pharmaceutical composition of metoprolol
WO2001080824A2 (en) Dual mechanism timed release dosage forms for low dose drugs
WO2005097079A2 (en) Controlled release dosage for gaba receptor agonist
PL200822B1 (pl) Kompozycja farmaceutyczna zawierająca rywastygminę
EP3184101A1 (en) Levodopa and carbidopa modified release composition
CZ2001984A3 (cs) Retardované farmaceutické vícesložkové přípravky nezávislé na míchání a způsob jejich výroby
WO2004050064A1 (en) Method of manufacturing controlled release formulation using pelletizer
MXPA01002821A (en) Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same